Display options
Cite
de Jaegere PPT, de Weger A, den Heijer P, et al. Treatment decision for transcatheter aortic valve implantation: the role of the heart team : Position statement paper of the Dutch Working Group of Transcatheter Heart Interventions. Neth Heart J. 2020;28(5):229-239doi: 10.1007/s12471-020-01367-4.
de Jaegere, P. P. T., de Weger, A., den Heijer, P., Verkroost, M., Baan, J., de Kroon, T., America, Y., & Brandon Bravo Bruinsma, G. J. (2020). Treatment decision for transcatheter aortic valve implantation: the role of the heart team : Position statement paper of the Dutch Working Group of Transcatheter Heart Interventions. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 28(5), 229-239. https://doi.org/10.1007/s12471-020-01367-4
de Jaegere, P P T, et al. "Treatment decision for transcatheter aortic valve implantation: the role of the heart team : Position statement paper of the Dutch Working Group of Transcatheter Heart Interventions." Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation vol. 28,5 (2020): 229-239. doi: https://doi.org/10.1007/s12471-020-01367-4
de Jaegere PPT, de Weger A, den Heijer P, Verkroost M, Baan J, de Kroon T, America Y, Brandon Bravo Bruinsma GJ. Treatment decision for transcatheter aortic valve implantation: the role of the heart team : Position statement paper of the Dutch Working Group of Transcatheter Heart Interventions. Neth Heart J. 2020 May;28(5):229-239. doi: 10.1007/s12471-020-01367-4. PMID: 31981094; PMCID: PMC7190764.
Copy Download .nbib Format: NLM
Share it on

Neth Heart J. 2020 May;28(5):229-239. doi: 10.1007/s12471-020-01367-4.

Treatment decision for transcatheter aortic valve implantation: the role of the heart team : Position statement paper of the Dutch Working Group of Transcatheter Heart Interventions.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

P P T de Jaegere, A de Weger, P den Heijer, M Verkroost, J Baan, T de Kroon, Y America, G J Brandon Bravo Bruinsma

Affiliations

  1. Department of Cardiology, Erasmus University, Rotterdam, The Netherlands. [email protected].
  2. Department of Cardiothoracic Surgery, University Hospital Leiden, Leiden, The Netherlands.
  3. Department of Cardiology, Amphia Ziekenhuis, Breda, The Netherlands.
  4. Department of Cardiothoracic Surgery, University Hospital Nijmegen, Nijmegen, The Netherlands.
  5. Department of Cardiology, Academic Medical Centre, Amsterdam, The Netherlands.
  6. Department of Cardiothoracic Surgery, Antonius Ziekenhuis Nieuwegein, Nieuwegein, The Netherlands.
  7. Department of Cardiology, Rijnstate Ziekenhuis Arnhem, Arnhem, The Netherlands.
  8. Department of Cardiothoracic Surgery, Isala Heart Centre, Isala Zwolle, The Netherlands.

PMID: 31981094 PMCID: PMC7190764 DOI: 10.1007/s12471-020-01367-4

Abstract

The current paper presents a position statement of the Dutch Working Group of Transcatheter Heart Valve Interventions that describes which patients with aortic stenosis should be considered for transcatheter aortic valve implantation and how this treatment proposal/decision should be made. Given the complexity of the disease and the assessment of its severity, in particular in combination with the continuous emergence of new clinical insights and evidence from physiological and randomised clinical studies plus the introduction of novel innovative treatment modalities, the gatekeeper of the treatment proposal/decision and, thus, of qualification for cost reimbursement is the heart team, which consists of dedicated professionals working in specialised centres.

Keywords: Aortic stenosis; Heart team; Surgical aortic valve replacement; Transcatheter aortic valve implantation; Transcatheter aortic valve replacement

References

  1. N Engl J Med. 2019 May 2;380(18):1695-1705 - PubMed
  2. J Am Coll Cardiol. 2017 Mar 14;69(10):1215-1230 - PubMed
  3. Circulation. 2018 May 15;137(20):2099-2100 - PubMed
  4. Eur Heart J. 2016 Feb 21;37(8):724-6 - PubMed
  5. N Engl J Med. 2019 May 2;380(18):1706-1715 - PubMed
  6. EuroIntervention. 2006 Feb;1(4):475-9 - PubMed
  7. J Thorac Cardiovasc Surg. 2009 Jan;137(1):82-90 - PubMed
  8. Circulation. 2008 Sep 30;118(14 Suppl):S234-42 - PubMed
  9. Eur Heart J. 2018 Jul 21;39(28):2635-2642 - PubMed
  10. Eur Heart J. 2017 Dec 1;38(45):3378-3381 - PubMed
  11. N Engl J Med. 2010 Oct 21;363(17):1597-607 - PubMed
  12. N Engl J Med. 2016 Apr 28;374(17):1609-20 - PubMed
  13. Lancet. 2016 May 28;387(10034):2218-25 - PubMed
  14. Heart. 2014 Jul;100(13):1016-23 - PubMed
  15. Heart. 2018 Feb;104(3):190-191 - PubMed
  16. N Engl J Med. 2000 Aug 31;343(9):652-4 - PubMed
  17. Eur Heart J. 2017 Sep 21;38(36):2739-2791 - PubMed
  18. Eur Heart J. 1992 May;13(5):704-8 - PubMed
  19. Eur Heart J. 2013 Jun;34(21):1597-606 - PubMed
  20. Heart. 2018 May;104(9):710-713 - PubMed
  21. EuroIntervention. 2007 Feb;2(4):500-5 - PubMed
  22. J Thorac Dis. 2017 Jun;9(6):1432-1436 - PubMed
  23. J Am Coll Cardiol. 2005 Jul 19;46(2):291-8 - PubMed
  24. N Engl J Med. 2017 Apr 6;376(14):1321-1331 - PubMed
  25. Eur Heart J. 2017 Dec 1;38(45):3341-3350 - PubMed
  26. Circ Cardiovasc Interv. 2014 Aug;7(4):439-40 - PubMed
  27. Circulation. 2002 Dec 10;106(24):3006-8 - PubMed
  28. Eur Heart J. 2017 Dec 1;38(45):3370-3377 - PubMed
  29. N Engl J Med. 2011 Jun 9;364(23):2187-98 - PubMed
  30. JAMA Cardiol. 2016 Apr 1;1(1):46-52 - PubMed

Publication Types